Loading...
•
Mar 31, 2021
Sotera Health Q1 2021 Earnings Report
Sotera Health's first quarter of 2021 resulted in double-digit revenue growth, meaningful net income growth, and double-digit Adjusted EBITDA growth.
Key Takeaways
Sotera Health reported a strong start to 2021 with double-digit revenue and Adjusted EBITDA growth. Net revenues for Q1 2021 increased by 13% to $212 million, and net income was $11 million, or $0.04 per diluted share. The company reaffirmed its 2021 outlook.
Q1 2021 net revenues increased 13% to $212 million compared to Q1 2020.
Q1 2021 net income was $11 million, or $0.04 per diluted share, compared to a net loss of $2 million in Q1 2020.
Q1 2021 Adjusted EPS increased 80% to $0.18, compared to $0.10 in Q1 2020.
The company reaffirmed its 2021 outlook.
Sotera Health
Sotera Health
Sotera Health Revenue by Segment
Revenue by Segment
Sterigenics Revenue
CapyFin.comNordion Revenue
CapyFin.comNelson Labs Revenue
CapyFin.com Forward Guidance
Sotera Health reaffirmed its 2021 outlook, which was first provided on March 9, 2021.
Positive Outlook
- Net revenues in the range of $890 million to $920 million, representing growth of approximately 9% to 12%, compared to the prior year.
- Adjusted EBITDA in the range of $465 million to $485 million, representing growth of approximately 11% to 16%, compared to the prior year.
- Tax rate applicable to Adjusted Net Income of approximately 28%.
- Adjusted EPS in the range of $0.78 to $0.86.
- Net leverage reduction of approximately 3⁄4 of a turn.
Revenue & Expenses
Visualization of income flow from segment revenue to net income